Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Asset Writedowns and Impairment (2023 - 2025)

Historic Asset Writedowns and Impairment for Metagenomi (MGX) over the last 3 years, with Q2 2025 value amounting to $181000.0.

  • Metagenomi's Asset Writedowns and Impairment fell 3418.18% to $181000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $933000.0, marking a year-over-year increase of 20690.79%. This contributed to the annual value of $1.0 million for FY2024, which is 443043.48% up from last year.
  • As of Q2 2025, Metagenomi's Asset Writedowns and Impairment stood at $181000.0, which was down 3418.18% from $752000.0 recorded in Q4 2024.
  • In the past 5 years, Metagenomi's Asset Writedowns and Impairment ranged from a high of $752000.0 in Q4 2024 and a low of $4000.0 during Q1 2024
  • For the 3-year period, Metagenomi's Asset Writedowns and Impairment averaged around $206166.7, with its median value being $97500.0 (2023).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first soared by 527142.86% in 2024, then plummeted by 3418.18% in 2025.
  • Metagenomi's Asset Writedowns and Impairment (Quarter) stood at $14000.0 in 2023, then skyrocketed by 5271.43% to $752000.0 in 2024, then tumbled by 75.93% to $181000.0 in 2025.
  • Its last three reported values are $181000.0 in Q2 2025, $752000.0 for Q4 2024, and $11000.0 during Q3 2024.